ArticleMissouri medicine
ADHD Diagnostic Trends: Increased Recognition or Overdiagnosis?
Article in Missouri medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 118 papers, 7 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
118 citing papers in PubMed, 7 syntheses or guidelines pooled it, 128 citations in OpenAlex.
- The Prevalence of Attention Deficit Hyperactivity Disorder in Psychotic Disorders: Systematic Review and Meta-analysis.Schizophrenia bulletin · 2025Pooled it
- Individual child factors affecting the diagnosis of attention deficit hyperactivity disorder (ADHD) in children and adolescents: a systematic review.European child & adolescent psychiatry · 2025Pooled it
- Internet gaming disorder, attention deficit hyperactivity disorder and learning in adults: a systematic review.Frontiers in psychiatry · 2025Pooled it
- Safety and efficacy of dasotraline for patients with attention deficit/hyperactivity disorder: a systematic review and meta-analysis of 1594 patients including GRADE qualifications.Psychopharmacology · 2025Pooled it
- Pooled it
- Methylphenidate abuse and misuse in patients affected with a psychiatric disorder and a substance use disorder: a systematic review.Frontiers in psychiatry · 2024Pooled it
- Genetic and Environmental Risk Factors for Intermittent Explosive Disorder, ADHD and Conduct Disorder: Shared and Unique Influences.Clinical psychology & psychotherapyPooled it
- Do Stimulants Promote Arrhythmic Risk: Insights From a Human-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model.Journal of arrhythmia · 2026Article
- Regulatory reform and adult methylphenidate dispensing in France: a nationwide interrupted time-series study.BMJ mental health · 2026Article
- Ethical and Legal Considerations in the Collection and Analysis of Mental Health Lived Experience Narratives: Reflections on 4 Case Studies of Research Practice.JMIR formative research · 2026Article
- Young minds in distress: Exploring the global rise in youth mental health diagnoses.Molecular psychiatry · 2026Review
- Is there evidence for additive neurocognitive deficits in adults with attention-deficit/hyperactivity disorder and co-occurring conditions?Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2026Article
- Prevalence of attention-deficit/hyperactivity disorder symptoms and associated factors among university students in Egypt: a cross-sectional study.Scientific reports · 2026Article
- Oral health status and associated influencing factors in children with attention-deficit/hyperactivity disorder: a case-control study.BMC oral health · 2026Article
- Trying to Survive in an Emotional Storm: A Qualitative Framework Analysis of Anonymous Youth Helpline Conversations on Mental Health and Everyday Life.Nursing reports (Pavia, Italy) · 2026Article
- Association between parental ADHD and adverse offspring outcomes: Evidence from a nationwide Swedish register-based study.Molecular psychiatry · 2026Article
- French Consumption of Methylphenidate in Primary Care From 2016 to 2023, Impact of Prescribing Policy Changes-A Time-Series Analysis.Pharmacoepidemiology and drug safety · 2026Article
- Effects of psychostimulants on locomotor activity in the BTBR TPsychopharmacology · 2026Article
- Incidence of ADHD diagnoses and medication initiation among children and adolescents in Norway from 2016-2024.European child & adolescent psychiatry · 2026Article
- Article
58 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
The prevalence of Attention Deficit Hyperactivity Disorder (ADHD) has seen a consistent rise in recent years. These numbers spark a debate over the reason for the observed trends, with some concerned about over diagnosis and over prescription of stimulant medications, and others raising the issue of diagnostic disparities, particularly in underrepresented populations. In this paper we look at both sides, starting with the history of ADHD and its diagnostic criteria changes, from early concepts of alterations in attention and hyperactivity in the 19th and 20th century, to its introduction in the Diagnostical and Statistical Manual of Mental Disorders (DSM), and its evolution into how it is defined today. The general broadening of ADHD diagnostically over time plays a role in the increased prevalence over the years, but it is not the only reason. Increased awareness of physicians and the public is also believed to play a big role, particularly in underrepresented minorities and women. However, there continues to be disparities in detection of ADHD in these groups. There are significant consequences to a patient's social, interpersonal, and professional life when ADHD is left unrecognized and untreated. Thoughtful evaluation, accurate diagnosis, and adequate treatment can make a big difference.
Indexed as
Identifiers
36337990PMC9616454W4308554985What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.